Robert M. Myers
Fondateur chez Orbus Therapeutics, Inc.
Profil
Robert M.
Myers is the founder of Orbus Therapeutics, Inc. Prior to founding Orbus Therapeutics, he worked as a Director at Cogentus Pharmaceuticals, Inc., President & Director at Jazz Pharmaceuticals Plc, Senior Vice President-Commercial Development at ALZA Corp., and Executive Vice President-Pharmaceuticals at Exelixis, Inc. He received his undergraduate, graduate, and MBA degrees from Stanford University.
Postes actifs de Robert M. Myers
| Sociétés | Poste | Début |
|---|---|---|
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Fondateur | - |
Anciens postes connus de Robert M. Myers
| Sociétés | Poste | Fin |
|---|---|---|
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Directeur/Membre du Conseil | 18/12/2009 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2003 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2001 |
| JAZZ PHARMACEUTICALS PLC | President | - |
Formation de Robert M. Myers
| Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
